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Identity 
HGNC (Hugo): RAC3 
Location: 17q25.3 
Local order: Located telomeric to the BROV region. 
Centromeric to LRRC45 - Rac3 - DCXR telomeric. 
Note 
With 5' end towards the centromere.  
Nucleotide 203731-2061912 of contig NT_010663. 
DNA/RNA 
Note 
6 exons, spread out over approximately 2,4 kb. 
Description 
The Rac3 gene encompasses 6 exons on chromosome 
17.  
Exon 1 encodes residues 1-12, exon 2 residues 13-36, 
exon 3 residues 37-75, exon 4 residues 76-96, exon 5 
residues 97-149 and exon 6 residues 150-192. 
Transcription 
Human Rac3 mRNA is a single species of around 1 kb. 
No splice variants have been reported.  
Factors that would regulate gene expression on a 
transcriptional level have not yet been reported. 
Pseudogene 




The Rac3 gene encodes a single protein of 192 amino 
acid residues. 
Description 
Rac3 is a small 21 kDa GTPase that acts as a molecular 
switch. In its active form, it is bound to GTP, whereas 
it is inactive in its GDP-bound form. Racs are 
controlled by guanidine activating proteins (GEFs) that 
exchange bound GDP for GTP and by GTPase 
activating proteins (GAPs) that promote GTP 
hydrolysis. Because of the hydrophobic isoprenyl 
moiety at the C-terminal end, it is associated with 
membranes. In the cytoplasm it associates with the 
chaperone RhoGDI. 
Expression 
Rac3 mRNA was reported in human cell lines 
including GM04155 (lymphoblastic leukemia), K562 
(CML), 5838 (Ewing sarcoma), HL60 (promyelocytic 
leukemia) and DU4475 (breast cancer). Rac3 
expression was reported using semi-quantitative 
RT/PCR in gastric tumor and adjacent normal tissue as 
well as gastric cancer cell lines. 
Expression of Rac3 using RT/PCR (38 cycles) was 
reported in human brain, liver, kidney and pancreas 
poly A RNA and also 19% of brain tumors expressed 
Rac3 mRNA. Rac3-specific polyclonal antibodies were 
used to show Rac3 protein in the brain (deep cerebellar 
nuclei and the pons) in 7 day old mice. 
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Schematic representation of the Rac3 protein (not to scale). Mutations that generate mutants that are locked in a certain 
conformation - constitutively active or dominant negative - are shown. The C-terminal end contains the CTVM motif that is post-
translationally modified the three last amino acid residues are removed and the C residue is geranyl-geranylated. 
 
Low level expression of mouse rac3 has been reported 
in bone-marrow-derived monocytes and in B-lineage 
lymphoblasts using standard and Real-Time RT/PCR. 
Expression of Rac3 is inferred because of the effect of 
siRNA knockdown in cell lines including HCT116 
colon cancer, MDA-MB231 breast cancer, HeLa, and 
PC3 prostate cancer (Zhu et al., 2011). Real-time 
RT/PCR showed Rac3 mRNA in prostate cancer 
biopsy samples (Engers et al., 2007). Analysis of gene 
expression profiling datasets (Chang et al., 2005) in 
breast cancer samples showed Rac3 expression (Walker 
et al., 2011). 
Localisation 
The Rac3 protein is located on endomembranes and 
cell membranes. Nuclear localization was also report d 
(Walker et al., 2011). 
Function 
Rac proteins regulate a variety of functions including 
cytoskeletal organization, cell cycle, reactive oxygen 
species production, and vesicle trafficking. In its 
activity on reactive oxygen species production, Rac3 is 
able to activate Nox1, Nox2 and Nox3 (Miyano et al.,
2009; Miyano and Sumimoto, 2012). Studies of null 
mutant Rac3 mice showed that Rac3 regulates 
cerebellar functions and in a mouse model plays a role 
in leukemia development caused by the Bcr/Abl 
oncogene. Point mutations (N26D, F37L, Y40C, 
N43D) were introduced into different critical residues 
of the effector domain of Rac3 and the effects of these 
were investigated on the ability of Rac3 to regulate 
membrane ruffles, c-jun activation and transformation. 
Transformation was assayed as the ability to cooperate 
with activated Raf in focus formation of NIH3T3 cells 
and the ability to promote growth of these cells in soft 
agar. Rac3 was found to negatively regulate autophagy 
in colon, breast and prostate cancer cell lines, since ts 
knockdown stimulated LC3-II expression (Zhu et al.,
2011). Different effects on migration are reported. 
Rac3 negatively regulates diapedesis of PC3 cells, 
since knockdown using siRNA increases migration of 
PC3 prostate cancer cells through a BMEC layer 
(Chatterjee et al., 2011). In contrast, overexpression of 
Rac3 in MCF7 breast cancer cells stimulates E2-
induced migration (Walker et al., 2011). 
Homology 
Rac3 is most closely related to Rac1 and Rac2. On a 
nucleotide level human Rac3 has 77% identity with 
Rac1, 83% identity with Rac2 and 69% identity with 
RhoG. On an amino acid level, Rac3 and Rac1 differ in 
14/192 residues (92% identical), whereas Rac3 and 
Rac2 differ in 22/192 residues (89% identical). Rac 
belongs to the extended Rho family of small G-
proteins. Biochemically, Rac1 and Rac3 are closely 
related and have overlapping (Corbetta et al., 2009; 
Pennucci et al., 2011; Basso et al., 2011) as well as 
distinct functions. Rac3 differs from Rac1 in the 
presence of a residue in its C-terminal end, S151, 
which is A151 in Rac1 and mediates binding of Rac3 to 
ERα (Walker et al., 2011). Rac3 and Rac1 also differ in 
their effect on NIE-115 neuroblastoma cells, in which 
Rac3 induces cell rounding and Rac1 induces spreading 





Using in situ hybridization, Rac3 was reported to lies 
outside of the BROV region commonly deleted in 
breast and ovarian cancer.  
Activated Rac3 protein was reported in MDA-435, 
T47D and MCF7 breast cancer cell lines and 1 of 3 
patient samples using a GST-Pak pull-down assay to 
detect activated Rac. 
siRNA against Rac3 inhibits SNB19 glioblastoma and 
BT549 breast cancer cell line invasion in an in vitro 
assay. 
It was showed that introduction of a constitutively 
active Rac3 into the MDA-MB-435 breast cancer cell 
line caused increased invasion and motility in vitro.  
Transgenic mice with tissue specific expression of  
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constitutively active (V12)Rac3 in the mammary gland 
were generated. Post-lactational female mice had 
delayed involution. 
In the MCF7 breast cancer cell line, E2-stimulated 
migration was decreased by siRNA-mediated 
knockdown of Rac3, and Rac3 interacted with the ERα 
in a ligand-dependent manner (Chatterjee et al., 2011).  
Meta-analysis of gene expression profiling datasets of 
breast cancer samples (Chang et al., 2005) for Rac3 
showed that expression levels correlated with increased 
probability of metastatic events (Walker et al., 2011). 
Gastric cancer 
Note 
Semi-quantitative RT/PCR was used to examine Rac3 
mRNA expression in gastric cancer tissues and 7 
gastric cell lines. Rac3 expression was detected in the 
tumor samples but there was no statistically significant 
difference between the expression levels in gastric 
cancer and adjacent non-tumorous tissues. The cell 
lines had a varying but detectable Rac3 expression. 
Brain tumors 
Note 
RT-PCR was used to evaluate Rac3 mRNA expression 
in human brain tumor tissues. Expression of rac3 was
reported in 3/9 meningiomas, 1/11 astrocytomas, 1/6 
pituitary adenomas. The PCR fragments were 
subcloned and sequenced, and mutations were reported 
in Rac3 in 12/19 brain tumors including E10V, V14E, 
D35N, P35S, N43D, V46A, D57V, R57P, L67V, S83F, 
V85A, E100G, H104L, P109H, R120H, T125P, S158P, 
P180T, V182E, V182A, H184L and G186E. 
Prostate cancer 
Note 
Using real-time RT/PCR, increased Rac3 mRNA was 
detected in involved prostate cancer biopsy samples 
compared to adjacent normal tissue (Engers et al., 
2007). 
To be noted 
Note 
There is a second gene that is named RAC3 in some 
publications.  
This protein is functionally and structurally unrelated to 
the small GTPase Rac3. This is the steroid receptor 
coactivator-3, or nuclear receptor coactivator SRC-
3/AIB1/ACTR/pCIP/RAC3/TRAM-1. 
Probes 1-12 from NM_005052-links-probes 
1: ProbeID:6597734 TaqMan gene expression 
(TaqMan) probe Hs00414037_g1 for Homo sapiens 
gene ras-related C3 botulinum toxin substrate 3 (rho 
family, small GTP binding protein Rac3) (RAC3). 
Developed for real time qRT-PCR gene expression 
profiling. Reagent is available from Applied 
Biosystems. 
2: ProbeID:3104502 Small interfering RNA (siRNA)  
probe for Homo sapiens gene ras-related C3 botulinum 
toxin substrate 3 (rho family, small GTP binding 
protein Rac3) (RAC3). Has been used for RNA 
interference (RNAi). Reference Chan et al., 2005 
3: ProbeID:3104501 Small interfering RNA (siRNA) 
probe for Homo sapiens gene ras-related C3 botulinum 
toxin substrate 3 (rho family, small GTP binding 
protein Rac3) (RAC3). Has been used for RNA 
interference (RNAi). Reference Chan et al., 2005 
4: ProbeID:1163472 Resequencing amplicon (RSA) 
probe RSA001057586 for Homo sapiens gene ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3). Developed 
for SNP discovery. 
5: ProbeID:1163461 Resequencing amplicon (RSA) 
probe RSA001057592 for Homo sapiens gene ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3). Developed 
for SNP discovery. 
6: ProbeID:1157480 Resequencing amplicon (RSA) 
probe RSA001229136 for Homo sapiens genes ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3) and leucine 
rich repeat containing 45 (LRRC45). Developed for 
SNP discovery. 
7. ProbeID:1152860 Resequencing amplicon (RSA) 
probe RSA001400685 for Homo sapiens genes ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3) and leucine 
rich repeat containing 45 (LRRC45). Developed for 
SNP discovery. 
8: ProbeID:1152824 Resequencing amplicon (RSA) 
probe RSA001401207 for Homo sapiens genes ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3) and leucine 
rich repeat containing 45 (LRRC45). Developed for 
SNP discovery. 
9: ProbeID:1151274 Resequencing amplicon (RSA) 
probe RSA001457703 for Homo sapiens gene ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3). Developed 
for SNP discovery. 
10: ProbeID:1151272 Resequencing amplicon (RSA) 
probe RSA001457859 for Homo sapiens gene ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3). Developed 
for SNP discovery. 
11: ProbeID:1151270 Resequencing amplicon (RSA) 
probe RSA001458006 for Homo sapiens gene ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3). Developed 
for SNP discovery. 
12: ProbeID:1151269 Resequencing amplicon (RSA) 
probe RSA001458005 for Homo sapiens gene ras-
related C3 botulinum toxin substrate 3 (rho family, 
small GTP binding protein Rac3) (RAC3). Developed 
for SNP discovery. 
13. Chan et al. (2005) reported TaqMan primers useful 
in quantifying human Rac3 expression. 
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14. Pan et al. (2004) reported primers for semi-
quantitative RT/PCR for human Rac3 that yielded a 
249 bp  
15. Hwang et al. (2005) reported primers for RT-PCR 
of human RNA. Fw primer was 5'-
AATTCATGCAGGCCATCAAGT-3' and the reverse 
primer 5'-CTAGAAGACGGTGCACTT-3'. 
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